Table 1 The distribution of BMA, H&E stained BMB and mammaglobin-1 IHC staining in our patient cohort.

From: Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases

Technique

No. of cases

%

p

BMA

0.0013*

Positive

0

0.0

Negative

30

100.0

H&E stained BMB

Suspicious

5

16.7

Negative

25

83.3

Mammaglobin-1 IHC staining

Positive

16

53.3

Negative

14

46.7

Back to article page